Abdominal Imaging

, Volume 40, Issue 5, pp 965–974 | Cite as

CT and MR enterography in Crohn’s disease: current and future applications

  • David H. BruiningEmail author
  • Gauraang Bhatnagar
  • Jordi Rimola
  • Stuart Taylor
  • Ellen M. Zimmermann
  • Joel G. Fletcher

Over the last two decades, radiologic imaging has become a vital component in the assessment of patients with known or suspected Crohn’s disease (CD). Increased utilization of cross-sectional imaging techniques has been driven by both disease- and patient-specific factors, as well as the realization that other clinical, laboratory, and even surgical evaluations may miss CD-related inflammation, penetrating complications, and obstructive disease. As a disease process, the protean symptoms of CD are often non-specific such as abdominal pain and diarrhea [1]. Even validated clinical indices of CD severity, such as the Crohn’s Disease Index of Activity (CDAI), the clinical endpoint for most therapeutic trials in CD, show poor correlation with biologic activity, especially in certain populations such as patients with fistulizing or obstructing disease [2, 3, 4]. In addition, there is little clinical suspicion of Crohn’s fistulae and strictures in a substantial proportion of patients with...


Crohn’s disease CT enterography MR enterography 



Crohn’s disease


Computed tomography


CT enterography


Inflammatory bowel disease


Magnetic resonance


MR enterography


Conflict of interest

JR: Robarts Clinical Trials (Consulting), AbbVie (Consulting), Bristol Myers Squibb (Consulting), Genentech (Research Support); ST: Robarts Clinical Trials (Consulting); and DHB, GB, EMZ, and JG declare that they have no conflict of interest.


  1. 1.
    Simren M, Axelsson J, Gillberg R, et al. (2002) Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 97(2):389–396PubMedGoogle Scholar
  2. 2.
    Cellier C, Sahmoud T, Froguel E, et al. (1994) Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 121 cases. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 35(2):231–235CrossRefPubMedCentralPubMedGoogle Scholar
  3. 3.
    Faubion WA Jr, Fletcher JG, O’Byrne S, et al. (2013) EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn’s disease activity: role of cross-sectional imaging. Am J Gastroenterol 108(12):1891–1900PubMedGoogle Scholar
  4. 4.
    Sandborn WJ, Feagan BG, Hanauer SB, et al. (2002) A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology 122(2):512–530CrossRefPubMedGoogle Scholar
  5. 5.
    Solem CA, Loftus EV, Fletcher JG, et al. (2008) Small-bowel imaging in Crohn’s disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 68(2):255–266PubMedGoogle Scholar
  6. 6.
    Booya F, Akram S, Fletcher JG, et al. (2009) CT enterography and fistulizing Crohn’s disease: clinical benefit and radiographic findings. Abdom Imaging 34(4):467–475PubMedGoogle Scholar
  7. 7.
    Samuel S, Bruining DH, Loftus EV Jr, et al. (2012) Endoscopic skipping of the distal terminal ileum in Crohn’s disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol 10(11):1253–1259PubMedGoogle Scholar
  8. 8.
    Siddiki HA, Fidler JL, Fletcher JG, et al. (2009) Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn’s disease. Am J Roentgenol 193(1):113–121Google Scholar
  9. 9.
    Buchanan G, Halligan S, Williams A, et al. (2002) Effect of MRI on clinical outcome of recurrent fistula-in-ano. Lancet 360(9346):1661–1662PubMedGoogle Scholar
  10. 10.
    Beets-Tan RG, Beets GL, van der Hoop AG, et al. (2001) Preoperative MR imaging of anal fistulas: does it really help the surgeon? Radiology 218(1):75–84CrossRefPubMedGoogle Scholar
  11. 11.
    Mako EK, Mester AR, Tarjan Z, Karlinger K, Toth G (2000) Enteroclysis and spiral CT examination in diagnosis and evaluation of small bowel Crohn’s disease. Eur J Radiol 35(3):168–175PubMedGoogle Scholar
  12. 12.
    Hara AK, Leighton JA, Heigh RI, et al. (2006) Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology 238(1):128–134CrossRefPubMedGoogle Scholar
  13. 13.
    Wold PB, Fletcher JG, Johnson CD, Sandborn WJ (2003) Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy—feasibility study. Radiology 229(1):275–281CrossRefPubMedGoogle Scholar
  14. 14.
    Paulsen SR, Huprich JE, Fletcher JG, et al. (2006) CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 26(3):641–657 (; discussion 657–662)CrossRefPubMedGoogle Scholar
  15. 15.
    Reittner P, Goritschnig T, Petritsch W, et al. (2002) Multiplanar spiral CT enterography in patients with Crohn’s disease using a negative oral contrast material: initial results of a noninvasive imaging approach. Eur Radiol 12(9):2253–2257PubMedGoogle Scholar
  16. 16.
    Vogel J, da Luz-Moreira A, Baker M, et al. (2007) CT enterography for Crohn’s disease: accurate preoperative diagnostic imaging. Dis Colon Rectum 50(11):1761–1769PubMedGoogle Scholar
  17. 17.
    Lee SJ, Park SH, Kim AY, et al. (2011) A prospective comparison of standard-dose CT enterography and 50% reduced-dose CT enterography with and without noise reduction for evaluating Crohn disease. Am J Roentgenol 197(1):50–57Google Scholar
  18. 18.
    Bruining DH, Siddiki HA, Fletcher JG, et al. (2012) Benefit of computed tomography enterography in Crohn’s disease: effects on patient management and physician level of confidence. Inflamm Bowel Dis 18(2):219–225PubMedGoogle Scholar
  19. 19.
    Higgins P, Caoili E, Zimmermann E, et al. (2007) Computed tomographic enterography adds information to clinical management in small bowel Crohn’s disease. Inflamm Bowel Dis 13(3):262–268PubMedGoogle Scholar
  20. 20.
    Booya F, Fletcher JG, Huprich JE, et al. (2006) Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology 241(3):787–795CrossRefPubMedGoogle Scholar
  21. 21.
    Bodily KD, Fletcher JG, Solem CA, et al. (2006) Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography—correlation with endoscopic and histologic findings of inflammation. Radiology 238(2):505–516CrossRefPubMedGoogle Scholar
  22. 22.
    Bruining DH, Loftus EV Jr, Ehman EC, et al. (2011) Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn’s disease. Clin Gastroenterol Hepatol 9(8):679–683 e671Google Scholar
  23. 23.
    Bruining DH, Loftus EV Jr (2008) Technology Insight: new techniques for imaging the gut in patients with IBD. Nat Clin Pract Gastroenterol Hepatol 5(3):154–161PubMedGoogle Scholar
  24. 24.
    Colombel JF, Solem CA, Sandborn WJ, et al. (2006) Quantitative measurement and visual assessment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 55(11):1561–1567CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Re GL, Cappello M, Tudisca C, et al. (2014) CT enterography as a powerful tool for the CDAI and acute-phase reactants. Radiol Med 119(9):658–666PubMedGoogle Scholar
  26. 26.
    Elsayes KM, Al-Hawary MM, Jagdish J, Ganesh HS, Platt JF (2010) CT enterography: principles, trends, and interpretation of findings. Radiographics 30(7):1955–1970CrossRefPubMedGoogle Scholar
  27. 27.
    Hanauer SB, Feagan BG, Lichtenstein GR, et al. (2002) Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet 359(9317):1541–1549PubMedGoogle Scholar
  28. 28.
    Rimola J, Rodriguez S, Garcia-Bosch O, et al. (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58(8):1113–1120CrossRefPubMedGoogle Scholar
  29. 29.
    Steward MJ, Punwani S, Proctor I, et al. (2012) Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81(9):2080–2088PubMedGoogle Scholar
  30. 30.
    Minordi LM, Vecchioli A, Poloni G, et al. (2009) Enteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn’s disease: CT findings and correlation with endoscopy. Eur Radiol 19(10):2432–2440PubMedGoogle Scholar
  31. 31.
    Mao R, Gao X, Zhu ZH, et al. (2013) CT enterography in evaluating postoperative recurrence of Crohn’s disease after ileocolic resection: complementary role to endoscopy. Inflamm Bowel Dis 19(5):977–982PubMedGoogle Scholar
  32. 32.
    Israeli E, Ying S, Henderson B, et al. (2013) The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel disease. Aliment Pharmacol Ther 38(5):513–521PubMedGoogle Scholar
  33. 33.
    Kerner C, Carey K, Mills AM, et al. (2012) Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn’s disease. Clin Gastroenterol Hepatol 10(1):52–57PubMedCentralPubMedGoogle Scholar
  34. 34.
    Vietti-Violi N, Fournier N, Duran R, et al. (2014) Acute mesenteric vein thrombosis: factors associated with evolution to chronic mesenteric vein thrombosis. Am J Roentgenol 203(1):54–61Google Scholar
  35. 35.
    Violi NV, Schoepfer AM, Fournier N, et al. (2014) Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss Inflammatory Bowel Disease Cohort. Am J Roentgenol 203(1):62–69Google Scholar
  36. 36.
    Weber NK, Fidler JL, Keaveny TM, et al. (2014) Validation of a CT-derived method for osteoporosis screening in IBD patients undergoing contrast-enhanced CT enterography. Am J Gastroenterol 109(3):401–408PubMedCentralPubMedGoogle Scholar
  37. 37.
    Klaus J, Armbrecht G, Steinkamp M, et al. (2002) High prevalence of osteoporotic vertebral fractures in patients with Crohn’s disease. Gut 51(5):654–658CrossRefPubMedCentralPubMedGoogle Scholar
  38. 38.
    Etzel JP, Larson MF, Anawalt BD, Collins J, Dominitz JA (2011) Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines. Inflamm Bowel Dis 17(10):2122–2129PubMedGoogle Scholar
  39. 39.
    Thayu M, Denson LA, Shults J, et al. (2010) Determinants of changes in linear growth and body composition in incident pediatric Crohn’s disease. Gastroenterology 139(2):430–438CrossRefPubMedCentralPubMedGoogle Scholar
  40. 40.
    Bilski J, Brzozowski B, Mazur-Bialy A, Sliwowski Z, Brzozowski T (2014) The role of physical exercise in inflammatory bowel disease. Biomed Res Int 2014:429031PubMedCentralPubMedGoogle Scholar
  41. 41.
    Masselli G, Gualdi G (2013) CT and MR enterography in evaluating small bowel diseases: when to use which modality? Abdom Imaging 38(2):249–259PubMedGoogle Scholar
  42. 42.
    Masselli G, Gualdi G (2012) MR imaging of the small bowel. Radiology 264(2):333–348CrossRefPubMedGoogle Scholar
  43. 43.
    Hara AK, Swartz PG (2009) CT enterography of Crohn’s disease. Abdom Imaging 34(3):289–295PubMedGoogle Scholar
  44. 44.
    Menys A, Atkinson D, Odille F, et al. (2012) Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn’s disease activity: a preliminary study. Eur Radiol 22(11):2494–2501PubMedGoogle Scholar
  45. 45.
    Menys A, Helbren E, Makanyanga J, et al. (2013) Small bowel strictures in Crohn’s disease: a quantitative investigation of intestinal motility using MR enterography. Neurogastroenterol Motil 25(12):967PubMedGoogle Scholar
  46. 46.
    Bickelhaupt S, Pazahr S, Chuck N, et al. (2013) Crohn’s disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin. Neurogastroenterol Motil 25(6):467–473PubMedGoogle Scholar
  47. 47.
    Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. (2011) Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis 17(5):1073–1080PubMedGoogle Scholar
  48. 48.
    Desmond AN, O’Regan K, Curran C, et al. (2008) Crohn’s disease: factors associated with exposure to high levels of diagnostic radiation. Gut 57(11):1524–1529CrossRefPubMedGoogle Scholar
  49. 49.
    Swanson G, Behara R, Braun R, Keshavarzian A (2013) Diagnostic medical radiation in inflammatory bowel disease: how to limit risk and maximize benefit. Inflamm Bowel Dis 19(11):2501–2508PubMedGoogle Scholar
  50. 50.
    Panes J, Bouhnik Y, Reinisch W, et al. (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7(7):556–585PubMedGoogle Scholar
  51. 51.
    Summers RM (2010) Dose reduction in CT: the time is now. Acad Radiol 17(10):1201–1202PubMedCentralPubMedGoogle Scholar
  52. 52.
    Kalra MK, Maher MM, Toth TL, et al. (2004) Techniques and applications of automatic tube current modulation for CT. Radiology 233(3):649–657CrossRefPubMedGoogle Scholar
  53. 53.
    Yanaga Y, Awai K, Nakaura T, et al. (2011) Hepatocellular carcinoma in patients weighing 70 kg or less: initial trial of compact-bolus dynamic CT with low-dose contrast material at 80 kVp. Am J Roentgenol 196(6):1324–1331Google Scholar
  54. 54.
    Kaza RK, Platt JF, Al-Hawary MM, et al. (2012) CT enterography at 80 kVp with adaptive statistical iterative reconstruction versus at 120 kVp with standard reconstruction: image quality, diagnostic adequacy, and dose reduction. Am J Roentgenol 198(5):1084–1092Google Scholar
  55. 55.
    Allen BC, Baker ME, Einstein DM, et al. (2010) Effect of altering automatic exposure control settings and quality reference mAs on radiation dose, image quality, and diagnostic efficacy in MDCT enterography of active inflammatory Crohn’s disease. Am J Roentgenol 195(1):89–100Google Scholar
  56. 56.
    Kambadakone AR, Prakash P, Hahn PF, Sahani DV (2010) Low-dose CT examinations in Crohn’s disease: impact on image quality, diagnostic performance, and radiation dose. Am J Roentgenol 195(1):78–88Google Scholar
  57. 57.
    Murphy KP, Crush L, McLaughlin PD, et al. (2015) The role of pure iterative reconstruction in conventional dose CT enterography. Abdom Imaging 40(2):251–257. doi: 10.1007/s00261-014-0222-x
  58. 58.
    Kambadakone AR, Chaudhary NA, Desai GS, et al. (2011) Low-dose MDCT and CT enterography of patients with Crohn disease: feasibility of adaptive statistical iterative reconstruction. Am J Roentgenol 196(6):W743–W752Google Scholar
  59. 59.
    Levesque BG, Sandborn WJ, Ruel J, et al. (2014) Converging goals of treatment for inflammatory Bowel disease, from Clinical Trials and Practice. Gastroenterology. doi: 10.1053/j.gastro.2014.08.003 PubMedGoogle Scholar
  60. 60.
    Oussalah A, Laurent V, Bruot O, et al. (2010) Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 59(8):1056–1065CrossRefPubMedGoogle Scholar
  61. 61.
    Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD (2000) Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 19(8):1059–1079PubMedGoogle Scholar
  62. 62.
    Rimola J, Ordas I, Rodriguez S, et al. (2011) Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 17(8):1759–1768PubMedGoogle Scholar
  63. 63.
    Ordas I, Rimola J, Rodriguez S, et al. (2014) Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology 146(2):374–382 e371Google Scholar
  64. 64.
    Tielbeek JA, Makanyanga JC, Bipat S, et al. (2013) Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity. Am J Roentgenol 201(6):1220–1228Google Scholar
  65. 65.
    Florie J, Horsthuis K, Hommes DW, et al. (2005) Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn’s disease. Clin Gastroenterol Hepatol 3(12):1221–1228PubMedGoogle Scholar
  66. 66.
    Horsthuis K, de Ridder L, Smets AM, et al. (2010) Magnetic resonance enterography for suspected inflammatory bowel disease in a pediatric population. J Pediatr Gastroenterol Nutr 51(5):603–609PubMedGoogle Scholar
  67. 67.
    Hyun SB, Kitazume Y, Nagahori M, et al. (2010) Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn’s disease. Inflamm Bowel Dis. doi: 10.1002/ibd.21510 PubMedGoogle Scholar
  68. 68.
    Laghi A, Borrelli O, Paolantonio P, et al. (2003) Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn’s disease. Gut 52(3):393–397CrossRefPubMedCentralPubMedGoogle Scholar
  69. 69.
    Sailer J, Peloschek P, Reinisch W, et al. (2008) Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol 18(11):2512–2521PubMedGoogle Scholar
  70. 70.
    Schreyer AG, Rath HC, Kikinis R, et al. (2005) Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut 54(2):250–256CrossRefPubMedCentralPubMedGoogle Scholar
  71. 71.
    Seiderer J, Herrmann K, Diepolder H, et al. (2007) Double-balloon enteroscopy versus magnetic resonance enteroclysis in diagnosing suspected small-bowel Crohn’s disease: results of a pilot study. Scand J Gastroenterol 42(11):1376–1385PubMedGoogle Scholar
  72. 72.
    Van Assche G, Herrmann KA, Louis E, et al. (2013) Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn’s disease. J Crohns Colitis 7(12):950–957PubMedGoogle Scholar
  73. 73.
    Takenaka K, Ohtsuka K, Kitazume Y, et al. (2014) Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn’s disease. Gastroenterology 147(2):334–342 e333Google Scholar
  74. 74.
    Buisson A, Joubert A, Montoriol PF, et al. (2013) Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn’s disease. Aliment Pharmacol Ther 37(5):537–545PubMedGoogle Scholar
  75. 75.
    Oto A, Kayhan A, Williams JT, et al. (2011) Active Crohn’s disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging 33(3):615–624PubMedGoogle Scholar
  76. 76.
    Chiorean MV, Sandrasegaran K, Saxena R, et al. (2007) Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterol 102(11):2541–2550PubMedGoogle Scholar
  77. 77.
    Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ (2013) Crohn’s disease complicated by strictures: a systematic review. Gut 62(7):1072–1084CrossRefPubMedGoogle Scholar
  78. 78.
    Adler J, Swanson SD, Schmiedlin-Ren P, et al. (2011) Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 259(1):127–135CrossRefPubMedCentralPubMedGoogle Scholar
  79. 79.
    Pazahr S, Blume I, Frei P, et al. (2013) Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn’s disease: initial experience. Magma 26(3):291–301PubMedGoogle Scholar
  80. 80.
    Zappa M, Stefanescu C, Cazals-Hatem D, et al. (2011) Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 17(4):984–993PubMedGoogle Scholar
  81. 81.
    Pariente B, Cosnes J, Danese S, et al. (2011) Development of the Crohn’s disease digestive damage score, the Lemann score. Inflamm Bowel Dis 17(6):1415–1422PubMedCentralPubMedGoogle Scholar
  82. 82.
    Pariente B, Mary JY, Danese S, et al. (2014) Development of the Lemann index to assess digestive tract damage in patients with Crohn’s disease. Gastroenterology. doi: 10.1053/j.gastro.2014.09.015 PubMedGoogle Scholar
  83. 83.
    D’Agostino RB Sr (2009) The delayed-start study design. N Engl J Med 361(13):1304–1306PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • David H. Bruining
    • 1
    Email author
  • Gauraang Bhatnagar
    • 2
  • Jordi Rimola
    • 3
  • Stuart Taylor
    • 2
  • Ellen M. Zimmermann
    • 4
  • Joel G. Fletcher
    • 5
  1. 1.Division of Gastroenterology and HepatologyMayo ClinicRochesterUSA
  2. 2.Centre for Medical ImagingUniversity CollegeLondonUK
  3. 3.Department of Radiology, Hospital Clinic BarcelonaUniversity of BarcelonaBarcelonaSpain
  4. 4.Division of Gastroenterology, Hepatology, and NutritionUniversity of Florida College of MedicineGainesvilleUSA
  5. 5.Department of RadiologyMayo ClinicRochesterUSA

Personalised recommendations